1-16 of 16
Paz Ribas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Unraveling Long-Term Survival of Multiple Myeloma Patients, the GEM2000 Experience

Rafael Alonso Fernandez, Andrés Arroyo Barea, Maria Teresa Cedena Romero, Laura Rosiñol Dachs, Javier de la Rubia, Sara Miqueleiz, Veronica Gonzalez-Calle, Felipe De Arriba, Luis Felipe Casado Montero, Miguel Teodoro Hernandez, Maria Mas Esteve, Pascual Fernandez, Paula Rodríguez-Otero, Carmen Calle Primo, Eugenia Abella, Paz Ribas, Adrian Alegre, Juan Miguel Bergua, Irene Gomez-Catalan, Jose Maria Arguiñano Perez, Luis Palomera, Enrique M Ocio, Maria Jose Busto Medina, Nieves Somolinos, Jose Maria Alonso Alonso, Aránzazu García Mateo, Joan Bargay, Pilar Delgado, Dunia De Miguel Llorente, Javier de la Cruz, Maria Victoria Mateos, Jesús F. San-Miguel, Joan Bladé, Juan-Jose Lahuerta Palacios, Joaquin Martinez Lopez
Journal: Blood
Blood (2024) 144 (Supplement 1): 1957.
https://doi.org/10.1182/blood-2024-211383
Published: 2024
Journal Articles

Alnuctamab (ALNUC; BMS-986349; CC-93269), a 2+1 B-Cell Maturation Antigen (BCMA) × CD3 T-Cell Engager (TCE), Administered Subcutaneously (SC) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 First-in-Human Clinical Study

Noffar Bar, Maria Victoria Mateos, Paz Ribas, Markus Hansson, Laura Paris, Craig C. Hofmeister, Paula Rodriguez Otero, Maria Aranzazu Bermúdez, Thomas Martin, Armando Santoro, Andrew J. Yee, Maria Creignou, Cristina Encinas Rodriguez, Claudio Cerchione, Javier De La Rubia, Albert Oriol, Heidi Waibel, Britta Besemer, Ethan Thompson, Brian Kiesel, Jinjie Chen, Alexander Chung, Isaac W. Boss, Allison Gaudy, Shaoyi Li, Kevin Hsu, Colin Godwin, Michael R. Burgess, Jesús San-Miguel, Luciano Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 2011.
https://doi.org/10.1182/blood-2023-180013
Published: 2023
Journal Articles

Clinical Characteristics, Treatment Approach and Long-Term Outcomes of 678 Patients with Symptomatic Waldenstrom's Macroglobulinemia: Comprehensive Insights from a Spanish Registry of IgM Gammapathies

Elham Askari, David F. Moreno, Fernando Escalante, Amalia Domingo-González, Angela Heredia, Arancha Bermúdez, Miguel Canales, Mario Arnao Herraiz, Maria Magdalena Alcala Peña, Ana Saus Carreres, Pablo Ríos Rull, María Casanova, Mercedes Gironella, Paz Ribas Garcia, Javier De La Rubia, Belén Navarro, María-Jesús Blanchard, Cristina Motlló, Ricarda García Sánchez, Francisco Taboada Alameda, Antonio Garcia, Eugenio Abella, Miguel Angel Alvarez Rivas, Joan Bargay, Laura Abril Sabater, Amanda Lopez Picado, Carlos Fernández de Larrea, Ramon Garcia-Sanz
Journal: Blood
Blood (2023) 142 (Supplement 1): 4406.
https://doi.org/10.1182/blood-2023-189581
Published: 2023
Journal Articles

Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study

Maria-Victoria Mateos, Paula Rodriguez Otero, Youngil Koh, Joaquin Martinez-Lopez, Gurdeep Parmar, H. Miles Prince, Hang Quach, Paz Ribas, Emil Hermansen, Vania T.M. Hungria, Sevgi Kalayoglu Besisik, Jin Seok Kim, Xavier Leleu, Valdas Pečeliūnas, Fredrik Schjesvold, Omur G. Sevindik, Tatiana Lavrova, Franck Dubin, Christine Devisme, Lucie Lepine, Sandrine Macé, Mony Morisse, Irene Ghobrial
Journal: Blood
Blood (2022) 140 (Supplement 1): 7317–7319.
https://doi.org/10.1182/blood-2022-157302
Published: 2022
Journal Articles

Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study

Sandy W. Wong, Noffar Bar, Laura Paris, Craig C Hofmeister, Markus Hansson, Armando Santoro, Maria-Victoria Mateos, Paula Rodríguez-Otero, Johan Lund, Cristina Encinas, Andrew J. Yee, Albert Oriol, Claudio Cerchione, Javier de la Rubia, Barbara Ferstl, Kristina Carlson, Paz Ribas, Arancha Bermúdez, Isaac W. Boss, Allison Gaudy, Shaoyi Li, Kevin Hsu, Colin D. Godwin, Michael R. Burgess, Jesús San-Miguel, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 400–402.
https://doi.org/10.1182/blood-2022-159009
Published: 2022
Journal Articles

Selinexor in Combination with Daratumumab-Bortezomib and Dexamethasone for the Treatment of Relapse or Refractory Multiple Myeloma: Initial Results of the Phase 2, Open-Label, Multicenter GEM-Selibordara Study

Paula Rodríguez-Otero, Veronica Gonzalez De La Calle, Anna Sureda, Felipe De Arriba, Marta Reinoso Segura, Paz Ribas, Ana Pilar Gonzalez, Yolanda Gonzalez-Montes, Albert Oriol, Joaquín Martínez-López, Marta Sonia Gonzalez, Miguel T Hernández, Maialen Sirvent, Joan Bladé Creixenti, Juan Jose Lahuerta, Jesús F. San-Miguel, Maria-Victoria Mateos
Journal: Blood
Blood (2021) 138 (Supplement 1): 1677.
https://doi.org/10.1182/blood-2021-147725
Published: 2021
Journal Articles

Renal Response in Relapsed Refractory Multiple Myeloma Patients with Severe Renal Impairment at treatment Initiation: Intermediate Data of a Large, Observational, Prospective Study

Antoni Garcia, Dr., Queralt Salas, Dra., Enrique Morales, Dr., González Esther, Dra., Maria Soledad Duran, MD, Fernando Escalante, Dr., Mercedes Gironella, Dra., Tomás Jose Gonzalez, Dr., Rafael Duro, Dr., Manuel Pérez, Dr., Paz Ribas, Elena Cabezudo, Rafael Lluch, Dr., Ignacio Español, Dr., Valentin Cabañas, Dr., Ricardo Francisco Garcia, Dr., Jose Antonio Márquez, Dr., Marta Duran, Javier Soriano, Javier de la Rubia
Journal: Blood
Blood (2017) 130 (Supplement 1): 1878.
https://doi.org/10.1182/blood.V130.Suppl_1.1878.1878
Published: 2017
Journal Articles

Activity and Safety of Daratumumab Monotheray in Patients with Relapsed and Refractory Multiple Myeloma Requiring Dialysis: Preliminary Results of Spanish, Retrospective, Multicenter Trial

Maria José Cejalvo, Mario Legarda, Eugenia Abella, Elena Cabezudo, Cristina Encinas, Ana García-Feria, Belén Iñigo, Jesús Marín, Paz Ribas, M. Ángeles Ruíz, Javier de la Rubia
Journal: Blood
Blood (2017) 130 (Supplement 1): 1866.
https://doi.org/10.1182/blood.V130.Suppl_1.1866.1866
Published: 2017
Journal Articles

Renal Response in Patients with Relapsed Refractory Multiple Myeloma: Interim Data of a Large, Observational, Prospective Study

Javier De La Rubia, Queralt Salas, MD, Enrique Morales, Esther González, Maria Soledad Durán, Fernando Escalante, Mercedes Gironella, Tomás José González-López, MD, Rafael Duro, Manuel Pérez, Paz Ribas, Elena Cabezudo, MD, Rafael Lluch, Ignacio Español, Valentin Cabañas, Ricardo García-Muñoz, Jose Antonio Márquez, Marta Duran, Javier Soriano, Antoni García
Journal: Blood
Blood (2016) 128 (22): 2114.
https://doi.org/10.1182/blood.V128.22.2114.2114
Published: 2016
Journal Articles

Analysis of Zoledronic ACID Therapy for Patients with Multiple Myeloma with Asymptomatic Biochemical Relaps.

Ramón García-Sanz, Albert Oriol, Javier De La Rubia, MD, Luis Palomera, MD, Paz Ribas, Miguel Teodoro Hernández, Maria José Moreno, Joan Bargay, Angel Ramírez, Ana Isabel Teruel, María Jesús Blanchard, Mercedes Gironella, MD, Miquel Granell, MD, Eugenia Abella, J.F. San Miguel
Journal: Blood
Blood (2012) 120 (21): 2967.
https://doi.org/10.1182/blood.V120.21.2967.2967
Published: 2012
Journal Articles

Clinical and Epidemiological Characteristics of Multiple Myeloma (MM): Comparison Between Hematopoietic Stem Cell Transplantation (HSCT) and Conventional Chemotherapy,

Gemma Ramirez, Consuelo Gonzalez Garcia, Ma Sol Durán, Javier De La Rubia, Alfons Soler, Inmaculada Castillo, Manuel Jurado, Paz Ribas, Ma Carmen Menchaca Echevarría, Miguel T. Hernandez, Ma Dolores López García-Carreño, Asunción Echeveste Gutierrez, Alicia Bailén Garcia, Silvia López, Jose Baquero
Journal: Blood
Blood (2011) 118 (21): 4166.
https://doi.org/10.1182/blood.V118.21.4166.4166
Published: 2011
Journal Articles

Outcomes In Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation Using Intravenous Busulfan and Melphalan: A Matched Comparison to a Double Autologous Transplant Strategy

Margarita Blanes, MD, Javier De La Rubia, Prof, Dr, PhD, Juan-Jose Lahuerta, MD, José David Gonzalez, MD, Paz Ribas, MD, Carlos Solano, MD, Miguel Angel Sanz, Dr, PhD
Journal: Blood
Blood (2010) 116 (21): 3560.
https://doi.org/10.1182/blood.V116.21.3560.3560
Published: 2010
Journal Articles

Epidemiological Study of Mutiple Myeloma In Spain: Efectiveness and Survival Analysis

Consuelo González García, Ma Sol Durán, Jose Ramón Mayans, Javier De La Rubia, Alfons Soler, Inmaculada Castillo, Paz Ribas, Ma Carmen Menchaca Echevarría, Manuel Jurado, Miguel T. Hernandez, Ma Dolores López García-Carreño, Asunción Echeveste Gutierrez, Joaquín Ruiz Arredondo, Silvia López, Gemma Ramirez
Journal: Blood
Blood (2010) 116 (21): 5044.
https://doi.org/10.1182/blood.V116.21.5044.5044
Published: 2010
Journal Articles

Toxicity and Early Response after Single Daily Dose of Intravenous Busulfan and Melphalan as Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma.

Margarita Blanes, MD, Javier de la Rubia, PhD, Juan J. Lahuerta, MD, Juan D. Gonzalez, MD, Paz Ribas, MD, Carlos Solano, MD, Miguel A. Sanz, PhD
Journal: Blood
Blood (2007) 110 (11): 4928.
https://doi.org/10.1182/blood.V110.11.4928.4928
Published: 2007
Journal Articles

Tandem Autologous Transplant Versus Reduced Intensity Conditioned Allogeneic Transplant (Allo-RIC) as Second Intensification in Chemosensitive Patients with Multiple Myeloma (MM) Not Achieving Complete Remission (CR) or Near-CR with a First Autologous Transplant. Results from a Spanish PETHEMA/GEM Study.

Joan Blade, MD, Laura Rosinol, MD, Juan Jose Lahuerta, MD, Anna Sureda, MD, Javier de la Rubia, MD, Jose Garcia-Larana, MD, Miguel Hernandez-Garcia, MD, Belen Hernandez-Ruiz, MD, Jose Antonio Perez-Simon, MD, Jose Luis Bello, MD, Dolores Carrera, MD, Maria Jesus Penarrubia, MD, Eugenia Abella, MD, Angel Leon, MD, Concepcion Poderos, MD, Juan Carlos Garcia-Ruiz, MD, Joan Besalduch, MD, Rafael Martinez-Martinez, MD, Isabel Perez-Fernandez, MD, Paz Ribas, MD, Jesus San Miguel, MD
Journal: Blood
Blood (2007) 110 (11): 729.
https://doi.org/10.1182/blood.V110.11.729.729
Published: 2007
Journal Articles

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

Clinical Trials & Observations
María-Victoria Mateos, José-M. Hernández, Miguel-T. Hernández, Norma-C. Gutiérrez, Luis Palomera, Marta Fuertes, Joaquín Díaz-Mediavilla, Juan-J. Lahuerta, Javier de la Rubia, María-José Terol, Ana Sureda, Joan Bargay, Paz Ribas, Felipe de Arriba, Adrian Alegre, Albert Oriol, Dolores Carrera, José García-Laraña, Ramón García-Sanz, Joan Bladé, Felipe Prósper, Gemma Mateo, Dixie-Lee Esseltine, Helgi van de Velde, Jesús-F. San Miguel
Journal: Blood
Blood (2006) 108 (7): 2165–2172.
https://doi.org/10.1182/blood-2006-04-019778
Published: 2006